To determine the effect of IACS-10759 on NIS activity, a separate cohort of tumour-bearing mice (n = 4) received 20 mg/kg IACS-10759 by oral gavage 24 h after baseline imaging and immediately before [18F]TFB PET-MR imaging. This evidence concerns the gene SLC5A5 and neoplasm.